Skip to main content

Advertisement

Table 2 Association between MX treatment and the occurrence of symptomatic congestive heart failure

From: Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study

Variable RR (CI)a p
Age 3.57 (0.98 – 19.9) 0.12
Gender 1.05 (0.70 – 2.40) 1
Disease duration 0.8 (0.7 – 1.1) 0.3
Cumulative dose 2.3 (1.54 – 3.66) 0.000003
Number of infusion 2.3 (1.4 – 3.8) 0.0003
  1. aRR = relative risk. CI = 95% confidence intervals